Clearmind Medicine Inc.
CMND· Nasdaq
CMNDClearmind Medicine Inc.
Source filing unavailable
| Metric | Q2 2025 | Q2 2024 |
|---|---|---|
| Net Income | -$783.93K | -$908.22K |
| EPS Diluted | -$0.16 | -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Clearmind Medicine Inc. · CIK 1892500 · Engraved from SEC EDGAR
